Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-02-06 @ 5:09 AM
Study NCT ID:
NCT02857920
Status:
COMPLETED
Last Update Posted:
2020-09-14
First Post:
2016-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
Sponsor:
Fuda Cancer Hospital, Guangzhou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NK-Bevacizumab
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |